Pro Forma Information - Vitro Acquisition

9 Months Ended

Sep. 30, 2016

Pro Forma Information – Vitro Acquisition

Pro Forma Information – Vitro Acquisition

16.  Pro Forma Information – Vitro Acquisition

Had the Vitro Acquisition, described in Note 15 and the related financing described in Note 8, occurred at the beginning of the period, unaudited pro forma consolidated net sales, earnings from continuing operations and earnings from continuing operations per share of common stock (diluted) would have been as follows:

	Three Months Ended September 30, 2015
	As		Acquisition		Financing		Pro Forma
	Reported		Adjustments		Adjustments		As Adjusted
Net sales	$	1,566	$	143	$		$	1,709
Earnings from continuing operations attributable to the Company	$	18	$	18	$	(11)	$	25
Diluted earnings per share from continuing operations		0.11					$	0.15

	Nine months ended September 30, 2015
	As		Acquisition		Financing		Pro Forma
	Reported		Adjustments		Adjustments		As Adjusted
Net sales	$	4,530	$	574	$		$	5,104
Earnings from continuing operations attributable to the Company	$	131	$	79	$	(46)	$	164
Diluted earnings per share from continuing operations	$	0.81					$	1.01